Our Team Archive - Page 8 of 16 - Tina’s Wish

Enter your keyword

Archives

Ronny Drapkin, MD, PhD & Jarrod Marto, PhD

Ronny Drapkin, MD, PhD & Jarrod Marto, PhD

Project Title: “Biomarker Discovery and Validation in Tissue Proximal Fluids”

Dr. Drapkin is an Associate Professor of Obstetrics, Gynecology and Pathology at the University of Pennsylvania and the Director of the Ovarian Cancer Research Center at Penn Medicine. Dr. Marto is an Associate Professor of Biological Chemistry and Molecular Pharmacology at Harvard Medical School and Director of the Blais Proteomics Center and Principal Investigator for the Department of Cancer Biology at Dana-Farber Cancer Institute. Dr. Drapkin and Dr. Marto are Co-Principal Investigators on this project.

Read more

Samuel C. Mok, PhD

Samuel C. Mok, PhD

Project Title: “Identification of ovarian cancer biomarkers in women at high risk of developing ovarian cancer using emerging EFIRM Liquid Biopsy (eLB) technology”

Dr. Mok holds the Stephanie C. Stelter Professorship in the Department of Gynecologic Oncology & Reproductive Medicine at The University of Texas MD Anderson Cancer Center.

Read more

Daniel A. Heller, PhD & Kara Long Roche, MD

Daniel A. Heller, PhD & Kara Long Roche, MD

Project Title: “Clinical Development of an Implantable Nanosensor for Early-Stage Ovarian Cancer Detection”

Dr. Heller is head of the Cancer Nanomedicine Laboratory at Memorial Sloan Kettering. Dr. Long Roche is a gynecologic oncologist at the Memorial Sloan Kettering Cancer Center. Dr. Long Roche and Dr. Heller are Co-Principal Investigators on this project.

Many thanks to Douglas A. Levine, MD, of NYU Perlmutter Cancer Center, for his contributions as Co-PI during the first phase of this project.

Read more

Andrew K. Godwin, PhD, Steven Soper, PhD, & Claudio Soto, PhD

Andrew K. Godwin, PhD, Steven Soper, PhD, & Claudio Soto, PhD

Project Title: “Developing a misfolded p53 aggregation assay to interrogate disease-specific exosomes captured using a microfluidic device for the early detection of epithelial ovarian cancer”

Dr. Godwin is the Chancellors Distinguished Chair in Biomedical Sciences, Endowed Professor, and Director of Molecular Oncology, Pathology and Laboratory Medicine at The University of Kansas Medical Center. In the fall of 2019, Dr. Godwin was named the recipient of the Dolph Simons Award in the Biomedical Sciences. Dr. Soper is a Foundation Distinguished Professor at The University of Kansas and holds joint appointments in the Departments of Chemistry and Mechanical Engineering. Dr. Soto is the Huffington’s Distinguished University Chair, Professor of Neurology and Director of George and Cynthia Mitchell Center for Alzheimer’s Disease and Related Brain Disorders at The University of Texas Medical School in Houston.

Read more

Ie-Ming Shih, MD, PhD

Ie-Ming Shih, MD, PhD

Project Title: “PapDREAMing for the detection of premalignant ovarian cancer”

Dr. Shih is a Richard W. TeLinde Distinguished Professor in the Department of Gynecology and Obstetrics at the Johns Hopkins University School of Medicine and a board-certified attending pathologist in the Division of Gynecologic Pathology at the Johns Hopkins Hospital.

Read more

DIPANJAN CHOWDHURY, PhD & KEVIN ELIAS, MD

DIPANJAN CHOWDHURY, PhD & KEVIN ELIAS, MD

Project Title: “Monitoring and detection of ovarian cancer using serum microRNA signatures in high-risk families”

Dr. Chowdhury is a Professor of Medicine at Harvard Medical School and Chief of the Division of Radiation and Genome Stability in the Department of Radiation Oncology at the Dana-Farber Cancer Institute. Dr. Elias is an Assistant Professor of Obstetrics, Gynecology and Reproductive Biology at Harvard Medical School and a Gynecologic Oncologist and Director of the Gynecologic Oncology Laboratory at Brigham And Women’s Hospital.

Read more